Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas

Current Oncology

Volumn 15, Issue 6, 2008, Pages 32-38

  Elhateer, H ^a   Muanza, Thierry ^a,b   Roberge, D ^a   Ruo, R ^a   Eldebawy, E ^a   Lambert, C ^a   Patrocinio, H ^a   Shenouda, G ^a   Souhami, L ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Fractionated stereotactic radiotherapy; Macroadenoma; Pituitary adenoma; Radiotherapy

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE;

ADULT; AGED; CANCER CONTROL; CANCER RADIOTHERAPY; CRANIOTOMY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS MACROADENOMA; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; PROLACTINOMA; RADIATION DOSE; REVIEW; STEREOTACTIC TREATMENT; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VISUAL FIELD DEFECT;

EID: 68749094102     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v15i6.293     Document Type: Review

References (30)

1. Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol 1976;15:261-73.
2. Roberge D, Shenouda G, Souhami L. Pituitary. In: Halperin EC, Perez CA, Brady LW, eds. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008: 751-64.
3. Brada M, Ajithkumar TV, Minniti G. Radiosurgery for pituitary adenomas. Clin Endocrinol (Oxf) 2004;61:531-43.
4. Sheehan JP, Niranjan A, Sheehan JM, et al. Stereotactic radiosurgery for pituitary adenomas: An intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 2005;102:678-91.
5. Paek SH, Downes MB, Bednarz G, et al. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 2005;61:795-808.
6. Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM. Radiotherapy for nonfunctioning pituitary adenomas: From conventional to modern stereotactic radiation techniques. Neurosurg Rev 2007;30:167-76.
7. Dekkers OM, de Keizer RJ, Roelfsema F, et al. Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma. Pituitary 2007;10:61-5.
8. Dekkers OM, Pereira AM, Roelfsema F, et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006;91:1796-801.
9. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 1991;68:860-6.
10. Laws ER Jr, Fode NC, Redmond MJ. Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients. J Neurosurg 1985;63:823-9.
11. Bohinski RJ, Warnick RE, Gaskill-Shipley MF, et al. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 2001;49:1133-44.
12. Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 2005;102:1004-12.
13. Brada M, Burchell L, Ashley S, Traish D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 1999;45:693-8.
14. Flickinger JC, Nelson PB, Taylor FH, Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989;63:2404-8.
15. Park P, Chandler WF, Barkan AL, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 2004;55:100-7.
16. Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 1993;38:571-8.
17. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:755-63.
18. Becker G, Kocher M, Kortmann RD, et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 2002;178:173-86.
19. Kong DS, Lee JI, Lim do H, et al. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 2007;110:854-60.
20. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 2002;97(suppl):408-14.
21. Leber KA, Berglöff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998;88:43-50.
22. Mitsumori M, Shrieve DC, Alexander E 3rd, et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998;42:573-80.
23. Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001;50:1279-86.
24. Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 2004;59:1088-96.
25. Cañón Rodríguez RM, Ortiz de Urbina D, Viera JC, et al. Fractionated stereotactic-guided radiotherapy in the treatment of pituitary adenomas [spanish]. Clin Transl Oncol 2005; 7:447-54.
26. Colin P, Jovenin N, Delemer B, et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: A prospective study of 110 patients. Int J Radiat Oncol Biol Phys 2005;62:333-41.
27. Voduc KD, Ma R, McKenzie M. Fractionated stereotactic radiotherapy (SRT) for pituitary adenomas [abstract 1543]. Proc Am Soc Clin Oncol 2005;23W. [Available online at: www.asco.org/ASCO/ Abstracts+%26+Virtual+Meeting/Abstracts?&vmview= abst_detail_view&confID=34&abstractID=32026; cited October 21, 2008]
28. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 2006;64:542-8.
29. Selch MT, Gorgulho A, Lee SP, et al. Stereotactic radiotherapy for the treatment of pituitary adenomas. Minim Invasive Neurosurg 2006;49:150-5.
30. McClelland S 3rd, Higgins PD, Gerbi BJ, Orner JB, Hall WA. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy. Technol Cancer Res Treat 2007;6:177-80.